3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
56
Squamous Cell Carcinoma of Head and Neck
31
Lung Neoplasms
17
Head and Neck Neoplasms
17
Urinary Bladder Neoplasms
16
Oropharyngeal Neoplasms
14
Nasopharyngeal Carcinoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Carcinoma
10
Small Cell Lung Carcinoma
9
Carcinoma, Squamous Cell
9
Uterine Cervical Neoplasms
8
Pancreatic Neoplasms
8
Ovarian Neoplasms
8
Carcinoma, Transitional Cell
8
Neoplasm Metastasis
7
Mouth Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Recurrence
6
Neoplasms
6
Mesothelioma, Malignant
6
Melanoma
6
Gallbladder Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Biliary Tract Neoplasms
6
Medulloblastoma
5
Laryngeal Neoplasms
5
Interventions
Trastuzumab
1
Cisplatin
1
Bleomycin
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasms, Second Primary
×
Cisplatin
×
Clear all
NCT03199300
2025-12-11
InvestiCAT
University Medical Center Groningen
Active not recruiting
20 enrolled